文献速递妇科

因宫颈癌或宫颈上皮内瘤变行子宫切除术后阴道上皮内瘤变的发生率:系统综述与Meta分析

Incidence of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Cancer or Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2025-08-07

该系统综述与Meta分析纳入48项研究、18,959例因宫颈上皮内瘤变(CIN)或宫颈癌行子宫切除术的患者,旨在评估术后病理确诊的阴道上皮内瘤变(VAIN)1级及以上(VAIN 1+)的发生率。结果显示VAIN 1+的合并发生率为2.7%(95%CI 1.8-3.7%),VAIN发生率为2.7%(95%CI 1.7-3.7%),阴道癌发生率为0.3‰(95%CI 0.0-1.0‰);与2000年前发表的研究相比,较近期研究中VAIN发生率逐渐升高。

要点

  • 因CIN或宫颈癌行子宫切除术后,每100例女性中近3例会发生VAIN 1+。
  • VAIN 1+的合并发生率为2.7%(95%CI 1.8-3.7%),阴道癌发生率为0.3‰(95%CI 0.0-1.0‰)。
  • 与2000年前发表的研究相比,较近期研究中VAIN发生率逐渐升高。

核心结论

  • 因CIN或宫颈癌行子宫切除术后,每100例女性中近3例会发生VAIN 1+。
  • 阴道上皮内瘤变的发生率随时间推移显著升高。

研究设计与样本

  • 系统检索PubMed、EMBASE和Cochrane对照试验中心注册库,检索时间从建库至2025年1月。
  • 共识别7,234项研究,其中48项纳入Meta分析。
  • 纳入因CIN或宫颈癌行子宫切除术的患者共18,959例。
  • 采用单组比例Meta分析估计VAIN 1+的发生率及95%CI。
  • 系统综述注册号:PROSPERO CRD42023433781。

主要发现

  • VAIN 1+的总体合并发生率为2.7%(95%CI 1.8-3.7%)。
  • VAIN的发生率为2.7%(95%CI 1.7-3.7%)。
  • 阴道癌的发生率为0.3‰(95%CI 0.0-1.0‰)。
  • 与2000年前发表的研究相比,较近期研究中VAIN发生率逐渐升高。

关键数值与推荐

  • 主要结局为因CIN或宫颈癌行子宫切除术后病理确诊的VAIN 1+(VAIN 1、2或3级或阴道癌)的发生率。
  • 次要结局为这些患者的临床病理特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the incidence of vaginal intraepithelial neoplasia (VAIN) 1+ in patients after hysterectomy for cervical intraepithelial neoplasia (CIN) or cervical cancer. DATA SOURCES: A systematic search was conducted in PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to January 2025. METHODS OF STUDY SELECTION: We identified 7,234 studies, 48 of which were included in the meta-analysis. The primary outcome was the incidence of pathologically confirmed VAIN 1+ (VAIN 1, 2, or 3 or vaginal cancer) in patients after hysterectomy for CIN or cervical cancer; the secondary outcome was the clinicopathologic characteristics of these patients. Single-proportion meta-analysis was performed to estimate the incidence and 95% CIs of VAIN 1+. TABULATION, INTEGRATION, AND RESULTS: A total of 18,959 patients who underwent hysterectomy for CIN or cervical cancer were included. The overall pooled incidence of VAIN 1+ was 2.7% (95% CI, 1.8-3.7%). The incidences of VAIN and vaginal cancer were 2.7% (95% CI, 1.7-3.7%) and 0.3‰ (95% CI, 0.0-1.0‰), respectively. The incidence of VAIN increased gradually in more recent studies compared with studies published before 2000. CONCLUSION: Nearly 3 of every 100 women develop VAIN 1+ after hysterectomy for CIN or cervical cancer. The rate of vaginal dysplasia has significantly increased over time. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42023433781.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Li R, Sun LF, Li RZ, et al. Incidence of Vaginal Intraepithelial Neoplasia After Hysterectomy for Cervical Cancer or Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-analysis. Obstet Gynecol. 2025. PMID: 40773750. doi:10.1097/AOG.0000000000006026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。